Capital Bank & Trust’s Exelixis EXEL Stock Holding History

Capital Bank & Trust’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-24	Closed	–	–	747
2018 Q3	$0	Hold	24	–	–	﹤0.01%	812
2018 Q2	$1K	Hold	24	–	–	﹤0.01%	661
2018 Q1	$1K	Sell	24 -3	-11%	-$83	﹤0.01%	628
2017 Q4	$1K	Buy	+27	New	+$718	﹤0.01%	672

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Bank & Trust's EXEL Position: Q4 2018 in Review

Capital Bank & Trust sold out of Exelixis (EXEL) in Q4 2018, closing a stake of 24 shares.

Capital Bank & Trust first reported a position in EXEL in Q4 2017 and held it in 4 quarters. The position peaked at $1K in Q2 2018. 344 funds tracked by Wall St. Rank hold EXEL as of Q4 2018.

Capital Bank & Trust reported no remaining Exelixis position as of Q4 2018 after selling out during the quarter.
Capital Bank & Trust sold 24 Exelixis shares in Q4 2018.
Capital Bank & Trust first reported a position in Exelixis in Q4 2017 and held it in 4 quarters.
Capital Bank & Trust's Exelixis position peaked at $1K in Q2 2018.
344 funds tracked by Wall St. Rank held Exelixis as of Q4 2018.

Based on Capital Bank & Trust's 13F filing for Q4 2018, filed 14 Feb 2019.